نتائج البحث

Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice.

• Authors : Sun, Hai-Jian^1,2,3 (AUTHOR) ; Ni, Zhang-Rong¹ (AUTHOR); Liu, Yao⁴ (AUTHOR)

• Source: Cardiovascular Diabetology. 4/25/2024, Vol. 23 Issue 1, p1-19. 19p.

تفاصيل العنوان

ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-/- mice.

• Authors : Svecla, Monika; Moregola, Annalisa; Dalt, Lorenzo Da

Subjects: WESTERN diet; BLOOD lipids; LIPID metabolism

• Source: Cardiovascular Diabetology; 11/30/2024, Vol. 23 Issue 1, p1-14, 14p

تفاصيل العنوان

Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway.

• Authors : Wu, Ya-Ru¹ (AUTHOR); Shi, Xiao-Yun² (AUTHOR); Ma, Chun-Yan¹ (AUTHOR)

• Source: Cardiovascular Diabetology. 11/9/2019, Vol. 18 Issue 1, p1-12. 12p. 1 Color Photograph, 6 Graphs.

تفاصيل العنوان

Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects.

• Authors : Leança, Camila C.¹ ; Nunes, Valéria S.¹ ; Panzoldo, Natália B.²

• Source: Cardiovascular Diabetology. 2013, Vol. 12 Issue 1, p1-15. 15p. 2 Charts.

تفاصيل العنوان

The predictive utility of circulating PCSK9 levels on diabetes mellitus.

• Authors : Peng, Jia¹ (AUTHOR); Zhu, Cheng-Gang¹ (AUTHOR); Li, Jian-Jun¹ (AUTHOR)

• Source: Cardiovascular Diabetology. 2/13/2021, Vol. 20 Issue 1, p1-3. 3p.

تفاصيل العنوان

Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study.

• Authors : Bhanpuri, Nasir H.; Hallberg, Sarah J.; Williams, Paul T.

Subjects: CARDIOVASCULAR diseases risk factors; TYPE 2 diabetes; CARDIOVASCULAR disease treatment

• Source: Cardiovascular Diabetology; 5/1/2018, Vol. 17 Issue 1, p1-16, 14p, 2 Charts, 2 Graphs

تفاصيل العنوان

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.

• Authors : Hayashi, Toshiyuki¹ ; Fukui, Tomoyasu¹; Nakanishi, Noriko¹

• Source: Cardiovascular Diabetology. 1/13/2017, Vol. 16, p1-13. 13p. 6 Charts, 2 Graphs.

تفاصيل العنوان

Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.

• Authors : Shi, Jie¹ (AUTHOR); Zhang, Weiwei¹ (AUTHOR); Niu, Yixin¹ (AUTHOR)

• Source: Cardiovascular Diabetology. 12/10/2020, Vol. 19 Issue 1, p1-13. 13p.

تفاصيل العنوان

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery.

• Authors : Demyanets, Svitlana¹; Kaun, Christoph²; Kaider, Alexandra³

• Source: Cardiovascular Diabetology. 2/26/2020, Vol. 19, p1-9. 9p.

تفاصيل العنوان

Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial.

• Authors : Fadini, Gian Paolo¹ ; Bonora, Benedetta Maria¹; Zatti, Giancarlo¹

• Source: Cardiovascular Diabetology. 4/4/2017, Vol. 16, p1-10. 10p. 1 Diagram, 3 Charts.

تفاصيل العنوان